ArticleScientific reports2025
Comparative in silico analysis of vapBC3 toxin-antitoxin system in Mycobacterium Bovis and Mycobacterium tuberculosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Toxin-Antitoxin (TA) systems are highly conserved genetic elements in the Mycobacterium tuberculosis complex, playing a critical role in bacterial survival, stress response, and persistence. Small variations in sequence composition can lead to species-specific functional differences, potentially influencing host adaptation, antibiotic tolerance, and virulence strategies. In this study, a comparative analysis of TA systems in M. tuberculosis and M. bovis was conducted using BLAST NCBI, and SnapGene 5.3.1. A main mutation was identified at nucleotide 719 of the vapC3 gene in M. bovis isolates. While vapC3 in M. tuberculosis consists of 137 amino acids, a nucleotide deletion in M. bovis resulted in a truncated protein of only 109 amino acids in the primary sequence, significantly altering its structure. These findings suggest potential differences in the translation and function of vapC3 between the two species. Molecular docking simulations were conducted using HADDOCK 2.4 to assess the functional implications of vapC3 mutations. The analysis revealed that VapBC3 in M. bovis exhibits a more stable interaction than in M. tuberculosis, which could be crucial in understanding species-specific toxin-antitoxin system functionality. Future studies should focus on the impact of this mutation on VapC3-mediated stress response, experimental validation and therapeutic applications targeting VapBC3-mediated bacterial survival pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.